Opendata, web and dolomites

LymphoDrain SIGNED

LymphoDrain: The definitive solution for chronic lymphedema

Total Cost €


EC-Contrib. €






 LymphoDrain project word cloud

Explore the words cloud of the LymphoDrain project. It provides you a very rough idea of what is the project "LymphoDrain" about.

solution    causing    trauma    le    becomes    wearable    physiological    first    drainage    grow    implanted    pain    chronic    injury    replaces    immobility    producing    economy    live    cure    social    garments    accumulation    urgent    skin    compression    infections    fluid       treat    obesity    832    therapies    normal    micro    disease    expectancy    risk    million    venous    constant    complications    worldwide    lymphodrain    lymph    impairments    minimally    disorder    ages    disfunction    function    constantly    earnings    billion    subcutaneous    life    healthcare    restore    daily    effect    implant    limbs    productive    prevalence    despite    pump    creates    care    additional    valued    lymphedema    invasive    externally    convert    continuous    flow    incapacity    treatments    global    reducing    health    cancer    patient    consists    genetic    resolution    country    arise    tissues    acute    closely    disorders    procedure    catheter    bills    lymphatica    physiotherapy    innovative    occurrence    lymphatic    device    population    disability    clear    financial    vessels    draining    caused    secondary    welfare    patients    definitive   

Project "LymphoDrain" data sheet

The following table provides information about the project.


Organization address
postcode: 1015
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 2˙586˙750 €
 EC max contribution 1˙810˙725 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2022-02-28


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LYMPHATICA MEDTECH SA CH (LAUSANNE) coordinator 1˙810˙725.00


 Project objective

Lymphedema (LE) is a chronic disfunction of the lymphatic system causing fluid accumulation in the limbs, which affects more than 100 million patients worldwide. Its occurrence is closely related to cancer, being a very common side effect of cancer therapies, but can also arise from genetic disorders or due to injury, trauma, venous disorders, obesity, immobility, etc. Despite recent advances, at present there is no cure for LE which becomes a chronic disorder. The disease must be treated constantly by the patient, to avoid complications, with daily use of compression garments, physiotherapy and skin care. Thus, it creates a constant disability for the patient and, more importantly, it affects his/her ability to work and to live a normal life. In Europe, the financial impact of LE is valued at around €832 million in health and social welfare bills, with an additional €2.3 billion used to treat infections secondary to LE, as well as an additional €4.4 billion in loss of earnings as a result of productive incapacity of the patients. In addition, the prevalence of chronic LE is expected to grow as the life expectancy increases and the global population ages. There is an urgent need for innovative approaches to restore continuous lymph flow drainage in affected tissues, producing a definitive solution for LE. Lymphatica´s subcutaneous implant, LymphoDrain, consists of a draining catheter and a micro-pump externally controlled by a wearable device, and replaces the function of lymphatic vessels. It is implanted via a minimally invasive procedure, and results in the resolution of the physiological impairments caused by LE reducing pain, the risk of potential complications and the need for additional treatments. Lymphatica´s goal is to convert LymphoDrain in the first definitive solution for LE patients and a clear solution for reducing the impact of LE on both the healthcare system and the economy of each country.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYMPHODRAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LYMPHODRAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Genetta (2019)

Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbing

Read More  

Siklu (2019)

Product validation of Software Defined Radio Chip for RRH that supports multiple frequency channels and ranges from Sub-6GHz to millimetre waves (mmWave)

Read More  

TOM-E (2019)

TOM-E is the first GPS navigation device that is the less expensive on the market and multimodal. With Tom-E, riding has never been easier.

Read More